MBX Biosciences, Inc. (MBX) — Dilution Risk Analysis
Current Snapshot
MBX Biosciences, Inc. (MBX) has a DilutionWatch score of 31/10 and is classified as MEDIUM risk. The score date in the source data is 2026-09-22T03:44:35.055802.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 31/10 Source (as of 2026-09-22T03:44:35.055802)
Recent SEC Filings
Recent filing forms in the source payload: 3 2, 4 5, 8-K 1.
| Form | Filed | Accession |
|---|---|---|
| 3 | 2026-03-18 | 0001193125-26-113899 |
| 4 | 2026-03-16 | 0001193125-26-107268 |
| 4 | 2026-02-27 | 0001193125-26-082562 |
| 8-K | 2026-02-05 | 0001193125-26-039475 |
| 4 | 2026-02-03 | 0001193125-26-035584 |
| 4 | 2026-02-03 | 0001193125-26-035587 |
| 3 | 2026-01-22 | 0001193125-26-018701 |
| 4 | 2026-01-22 | 0001193125-26-018702 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 62 months | Source |
| Three-year share count growth | 57.85% | Source |
DilutionWatch Analysis
- Risk Level
- MEDIUM (Score: 31/10) Source
- Cash Runway
- 62 months Source
- Share Count Growth (3-Year)
- 57.85% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.